{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "C-end Rule",
      "internalization",
      "neuropilin",
      "virus"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34772761",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e2112457118",
      "10.1073/pnas.2112457118"
    ],
    "Journal": {
      "ISSN": "1091-6490",
      "JournalIssue": {
        "Volume": "118",
        "Issue": "49",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov",
          "Day": "16"
        }
      },
      "Title": "Proceedings of the National Academy of Sciences of the United States of America",
      "ISOAbbreviation": "Proc Natl Acad Sci U S A"
    },
    "ArticleTitle": "A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.",
    "Abstract": {
      "AbstractText": [
        "Many phylogenetically distant animal viruses, including the new coronavirus severe acute respiratory syndrome coronavirus 2, have surface proteins with polybasic sites that are cleaved by host furin and furin-like proteases. Other than priming certain viral surface proteins for fusion, cleavage generates a carboxy-terminal RXXR sequence. This C-end Rule (CendR) motif is known to bind to neuropilin (NRP) receptors on the cell surface. NRPs are ubiquitously expressed, pleiotropic cell surface receptors with important roles in growth factor signaling, vascular biology, and neurobiology, as well as immune homeostasis and activation. The CendR-NRP receptor interaction promotes endocytic internalization and tissue spreading of different cargo, including viral particles. We propose that the interaction between viral surface proteins and NRPs plays an underappreciated and prevalent role in the transmission and pathogenesis of diverse viruses and represents a promising broad-spectrum antiviral target."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 the Author(s). Published by PNAS."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3585-559X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland."
          },
          {
            "Identifier": [],
            "Affiliation": "Queensland Brain Institute, The University of Queensland, Brisbane, QLD 4072, Australia."
          }
        ],
        "LastName": "Balistreri",
        "ForeName": "Giuseppe",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "School of Cellular and Molecular Medicine, Faculty of Life Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya 4648602, Japan."
          }
        ],
        "LastName": "Yamauchi",
        "ForeName": "Yohei",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0002-9458-6385"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Precision and Nanomedicine, University of Tartu 50411 Tartu, Estonia; tambet.teesalu@ut.ee."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Nanomedicine, University of California, Santa Barbara, CA 93106."
          }
        ],
        "LastName": "Teesalu",
        "ForeName": "Tambet",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Proc Natl Acad Sci U S A",
    "NlmUniqueID": "7505876",
    "ISSNLinking": "0027-8424"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Neuropilins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Neuropilins"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    }
  ],
  "CoiStatement": "Competing interest statement: T.T. is the inventor of iRGD and CendR peptides and a shareholder of Cend Therapeutics Inc., a company that holds a license for the iRGD and CendR peptides."
}